No Data
No Data
Emerging Markets outlook: Attention may turn towards lightly traded ultra-low-priced stocks and biotech-related stocks.
■ Emerging Markets outside of the investment radar. This week, Emerging Markets declined. During the same period, while the Nikkei average dropped by -1.95%, the Growth Market Index fell by -2.67% and the Growth Market 250 Index decreased by -3.09%, indicating that Emerging Markets were relatively weak. As attention turns to the central bank meetings in Japan and the US, reports of Nissan <7201> and Honda <7267> beginning discussions on a management integration have led to speculation surrounding Main Board auto stocks and Auto Parts suppliers, leaving Emerging Markets outside of active investment consideration.
The Tokyo Stock Exchange's Growth Index has fallen back, with the recovery weak and remaining sluggish in the negative zone.
Tokyo Stock Exchange Growth Market Index 810.03 -5.78 / Volume 0.2 billion 56 million shares / Trading value 128.7 billion yen. Tokyo Stock Exchange Growth Market 250 Index 630.85 -5.00 / Volume 0.1 billion 18.53 million shares / Trading value 80.7 billion yen. Today's growth market saw both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index fall back. The number of rising stocks was 194, declining stocks numbered 369, and unchanged stocks were 38. The growth market today was weak. The previous day, October 18, in the USA.
Stocks that moved the day before part 2: Osaka Chemical Industry, Liberta, Terra Drone, ETC.
Stock Name <Code> Closing Price on 17th ⇒ Change from Previous Day SHIFT <3697> 16,970 -705 JP Morgan Securities has downgraded its investment rating. Sakura Internet <3778> 4,260 -265 fell below the 4,500 yen level. Double Scope <6619> 266 -6 experienced a dominant trend of short-term investor sell-offs due to sluggish movements. Monex Group <8698> 1,016 -48 saw a dominant trend of sell-offs from short-term investors after falling below the 25-day moving average. JCR Pharma <4
Stocks that hit the upper or lower limit in the afternoon session.
■ Limit up <218A> Liberaware <3992> Needswell <4124> Osaka Yuka Kogyo <4576> De Western Therapeutics Research Institute <4894> Qualips <4935> Liberta <5134> POPER <5888> DAIWA CYCLE <7378> Asiro <8783> GFA ■ Limit down <3775> Gaia Inc <7034> Proled Partners *Includes temporary limit up/down (indicative price).
Emerging Markets Stock Digest: DWTI and Daiwa Cycle hit the daily limit.
Fanpeep (4881) is in a slight decline of 130. It was announced that a joint collaboration agreement has been signed with i-Brain Science regarding the Alzheimer’s Disease Vaccine. i-Brain Science has already obtained regulatory approval for the neuropsychological testing program 'Milevo,' which uses a generic tablet as a diagnostic aid for dementia, on October 5, 2023. The company is conducting drug discovery research for an Alzheimer’s Disease Vaccine targeting 'phosphorylated tau' from November 2023.
Volume change rate ranking (14:00) ~ Ashiro, MIXI, ETC are ranked.
In the Volume change rate ranking, by comparing the average Volume over the past five days with the Volume on the day of distribution, it is possible to understand the trends of market participants' interest, etc. ■ Top Volume Change Rates [As of December 17, 14:32] (Comparison of the last five days' average Volume) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Price Change Rate <7378> Asiro 1748200122872.9325.82% 0.1044% <7965> Zojirushi 9